NCT00443521View on ClinicalTrials.gov

Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

July 31, 2006

Conditions
Diabetic Retinopathy
Interventions
DRUG

Triamcinolone Acetonide 4 mg intravitreal injection

PROCEDURE

Panretinal photocoagulation

Trial Locations (1)

05403-000

Retina and Vitreous Service, Department of Ophthalmology. Hospital das Clínicas. University of São Paulo School of Medicine, São Paulo

All Listed Sponsors
collaborator

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

OTHER_GOV

lead

University of Sao Paulo

OTHER

NCT00443521 - Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy | Biotech Hunter | Biotech Hunter